Cite
HARVARD Citation
Feist, E. et al. (n.d.). P131 Efficacy and safety of olokizumab in a phase III trial of patients with moderately to severely active RA inadequately controlled by methotrexate: placebo and active controlled study. Rheumatology. p. . [Online].